Monovisc
Monovisc Description
Monivisc is an injection treatment with a high concentration of highly purified, partially cross-linked sodium hyaluronate (NaHA). It delivers the supplement into the knee joint, relieving pain caused by osteoarthritis. This viscosupplement is the best choice for patients, who can’t experience pain relief from oral painkillers, exercises, or weight loss. Monivisc injection is approved for use in the US with no pseudoseptic reactions reported. The injection provides effective results that can last up to 6 months.
Benefits of Monovisc
- Contains highly purified hyaluronic acid concentration derived from non-animal sources
- Safe and convenient single injection with no pseudoseptic reactions reported.
- Delivers the substance directly into the knee joint to improve the lubrication of the joint fluid.
- Provides long-lasting pain relief
Monovisc Packaging
- 1 x 4 ml
Monovisc Indications
- Osteoarthritis (OA) knee pain
Contraindications
- Not intended for patients with existing infections near the injection site
- Not recommended for individuals with known infection of the index joint
- Not suitable for patients with bleeding disorders
Tous les avis
0
Ingrédients
Sodium hyaluronate (22 mg/ml), Hyaluronic acid (88mg)
Zone d’application
Knee joint
Fabricant
Anika Therapeutics, Inc.
Type de produit
Viscosupplement
Volume
1 x 4 ml
Marque
Monovisc®
Pays d’origine
United States
Create a Review
Monovisc